ID   LS2 [Human liposarcoma]
AC   CVCL_D3X8
DR   GEO; GSM484740
DR   GEO; GSM484741
DR   GEO; GSM484742
DR   GEO; GSM484745
DR   GEO; GSM484746
DR   Wikidata; Q127382706
RX   PubMed=20197395;
CC   Population: African American.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
DI   NCIt; C3705; Pleomorphic liposarcoma
DI   ORDO; Orphanet_99969; Pleomorphic liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
RX   PubMed=20197395; DOI=10.1158/1535-7163.MCT-09-0705; PMCID=PMC2837520;
RA   Mitchell M.A., Johnson J.E., Pascarelli K., Beeharry N., Chiourea M.,
RA   Gagos S., Lev D.C., von Mehren M., Kipling D., Broccoli D.;
RT   "Doxorubicin resistance in a novel in vitro model of human pleomorphic
RT   liposarcoma associated with alternative lengthening of telomeres.";
RL   Mol. Cancer Ther. 9:682-692(2010).
//